BioAmber Inc Stock Prediction and Forecast [BIOA]
1 extracted signal · 1 resolved · 0 still active
StockInvest.usIndependent analyst profile- Source published
- 07 Jan 2026, 04:36 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC
![Video preview for BioAmber Inc Stock Prediction and Forecast [BIOA]](https://i.ytimg.com/vi/sTkQz1ySbtU/hqdefault.jpg)
AI-generated source summary
The analysis rates BioAmber Inc (BIOA) as a Strong Buy Candidate with a score of 8.221, reflecting a 187.50% gain over 54 days. The stock is identified within a broad, robust upward trend in the short term, with an anticipated retreat towards the lower trend section presenting a short-term selling opportunity. A breakout above $15.62 would signal accelerated growth. Over the next three months, a 155.57% increase is projected, leading to a target price of $39.38. The 12-month analysis suggests a 69.21% increase, with an anticipated price range of $13.15 to $26.08. On January 6th, 2026, BIOA closed at $15.41, a 22.11% gain, with increased volume and is 4.76% below its 52-week high of $16.18. Technical signals are mixed, with a short-term MACD sell signal, but buy signals from Pivots, Bollinger Bands, and Moving Averages. However, long-term Moving Averages show sell signals. The stock exhibits medium daily volatility (11.50%) and medium risk. Support is found at $13.39 and $12.62. The P/E ratio is negative (-7.29), indicating negative earnings with a consensus estimate of -$1.01 for Q4 2025. Insider trading shows significantly more buys than sells, reflecting positive sentiment. A suggested stop-loss is $14.86. For January 7th, 2026, BioAmber is expected to open lower at $14.63.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
StockInvest.us
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.